Clearance is
provided consistent with the understanding that the results of this
study will not be represented as generalizable. The population
served by the study site is not representative of the US population
and the single health care system studied cannot be assumed to be
representative of any particular provider model. Furthermore, as
noted in the supporting statement, the internal(practice-based)
sampling approach used is not suitable for drawing statistically
rigorous comparisons. Rather, qualitative analysis will be used to
gain insights into how, how well, and how easily different types of
practices incorporate the system redesign intervention.
Inventory as of this Action
Requested
Previously Approved
12/31/2010
24 Months From Approved
9,877
0
0
2,047
0
0
0
0
0
The proposed study, Health Care
Systems for Tracking Colorectal Cancer Screening Tests (contract
number: HHSA290200600014, task order #1; task order number:
290-06-0014-1) is consistent with AHRQ's mission, as it will
implement and assess a system redesign intervention to improve
colorectal cancer (CRC) screening and follow-up among patients 50 -
79 years-old. The primary purpose of this study is to determine
whether a system redesign intervention previously shown to be
effective for increasing CRC screening and follow up rates in one
setting can be successfully disseminated to other settings and to
identify conditions and attributes associated with successful
dissemination and uptake. This study will synthesize and
disseminate information about appropriate CRC screening
recommendations (that are consistent with 2008 American Cancer
Society Guidelines) to both providers and patients at selected
primary care practices. It will also provide a mechanism for
facilitating CRC screening tests, monitoring the test results,
informing providers of the results, and facilitating appropriate
follow up through feedback to providers and subsequently patients.
This in turn, is expected to help improve the quality of health
care and its delivery. The study's analysis will determine to what
extent this intervention was disseminated effectively and
successfully and identify facilitators and barriers to effective
and successful dissemination. It will also provide valuable
information and "lessons learned" to other health care practices,
delivery networks, and insurers that are interested in increasing
CRC screening and follow up rates.
US Code:
42
USC 299 Name of Law: Healthcare Research and Quality Act of
1999
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.